15 Nov 2016 Dynavax Receives Complete Response Letter from U.S. Food and Drug Administration for Biologics License Application for HEPLISAV-B
15 Nov 2016 Transgene Presents Preclinical Results of TG1050, an HBV-targeted Immunotherapy, at AASLD 2016 Liver Meeting
14 Nov 2016 CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine is Successful in Treating Rheumatoid Arthritis
14 Nov 2016 Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
14 Nov 2016 Aduro Biotech Highlights Positive Clinical Results from Second Cohort of Phase 1b Mesothelioma Clinical Trial
10 Nov 2016 Inovio Pharmaceuticals Zika Vaccine Protects Animals from Infection, Brain Damage and Death
08 Nov 2016 Madison Vaccines Says Promising Early Data on the Combination of Its Lead Prostate Cancer Vaccine with a PD-1 Inhibitor Will Be Presented at Major Medical Meeting Nov. 11th
08 Nov 2016 DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients
08 Nov 2016 GeoVax and ViaMune to Collaborate on Cancer Immunotherapy Program
07 Nov 2016 CryoVax(R) : Next Generation Immunotherapy for Metastatic Colorectal Cancer Begins USA Phase IIb Clinical Trial
07 Nov 2016 Neovacs enrolls the first U.S. Patient in Phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE)
07 Nov 2016 Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine
04 Nov 2016 ARTES and BioSun Announce Co-Development for HPV Vaccine
28 Oct 2016 Opiant Pharmaceuticals, Inc. Licenses Heroin Vaccine From Walter Reed Army Institute of Research and National Institute on Drug Abuse
28 Oct 2016 Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
27 Oct 2016 Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research
26 Oct 2016 PharmaJet® and Vaccibody collaborate on HPV vaccine development
25 Oct 2016 Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut
25 Oct 2016 GSK announces US regulatory submission of candidate vaccine for prevention of shingles
24 Oct 2016 Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed
24 Oct 2016 Aduro Biotech Reports Partial Clinical Hold to Pause Enrollment in LADD Trials
20 Oct 2016 Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection
19 Oct 2016 Canadian Ebola vaccine enters new trial phase
17 Oct 2016 First Patient Randomized in Multiple Dose Cohort of Phase 1/1b Trial with Transgene’s TG1050 in Chronic Hepatitis B Patients
17 Oct 2016 Hookipa Secures EUR 4.16 Million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing